Skip to main content
SpringerLink
Log in

Immunogenetic markers in patients with Graves' disease

  • Originals
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

110 carefully characterized Caucasoid patients with Graves' disease were tested for HLA class I and class II antigens. Compared with Caucasian controls (n=193), the frequencies of HLA B8, Cw7 and DR3 were significantly increased (pc<0.05). In the subgroups with and without exophthalmos, HLA A3 exhibited a negative but insignificant association with the eye involvement, while A19 and Cw2 showed positive, however even weaker correlations with eye disease. HLA DR5 was associated with relapsing thyrotoxicosis, whereas HLA DR7 and B12 were negatively correlated with relapse. These results confirm the positive correlation of HLA B8 and DR3 with Graves' disease and reveal a not yet observed association with Cw7. Reported correlations of antigen frequencies with eye disease and relapsing thyrotoxicosis could not be confirmed. Other previously unknown, however subtle differences in disease subgroups were observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

EF:

etiologic fraction

HLA:

Human leukocyte antigens

RR:

relative risk

TRAb:

TSH receptor antibodies

TSH:

Thyroid stimulating hormone

References

  1. Albert ED, Baur MP, Mayr WR (eds) (1984) Histocompatibility Testing 1984. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  2. Allannic H, Fauchet R, Lorcy Y, Gueguen M, Le Guerrier A-M, Genetet B (1983) A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype. J Clin Endocrinol Metabol 57:719–722

    Google Scholar 

  3. Balazs CS, Stenszky V, Kozma L, Leovey A (1978) The possible influence of HLA-A1, B8 antigens on the course of Graves' disease. Biomedicine 29:263–264

    Google Scholar 

  4. Bech K, Lumholtz BO, Nerup J, Thomsen M, Platz P, Ryder LP, Svejgaard A, Nielsen KS, Hensen JM, Larsen JH (1977) HLA antigens in Graves' disease. Acta Endocrinol (Copenhagen) 86:510–516

    Google Scholar 

  5. Dahlberg PA, Holmlund G, Karlsson FA, Säfwenberg J (1981) HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course. Acta Endocrinol (Copenhagen) 97:42–47

    Google Scholar 

  6. de Bruin TWA, Bolk JH, Bussemaker JK, Stijnen T, Schreuder GMT, de Vries RRP, van der Heide D (1988) Graves' disease: immunological and immunogenetic indicators of relapse. Br Med J 296:1292–1295

    Google Scholar 

  7. Farid NR, Stone E, Johnson G (1980) Graves' disease and HLA. Clinical and epidemiological associations. Clin Endocrinol 13:535–544

    Google Scholar 

  8. Farid NR, Thompson C (1986) HLA and autoimmune endocrine disease 1985. Mol Biol Med 3:85–97

    Google Scholar 

  9. Frecker M, Stenszky V, Balazs C, Kozma L, Kraszits E, Farid NR (1986) Genetic factors in Graves' ophthalmopathy. Clin Endocrinol 25:479–485

    Google Scholar 

  10. Frecker M, Preus M, Kozma L, Kraszits E, Stenszky V, Balazs C, Farid NR (1986) Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers. Mol Biol Med 3:63–71

    Google Scholar 

  11. Irvine WJ, Gras RS, Morris PJ, Ting A (1977) Correlation of HLA and thyroid antibodies with clinical course of thyrotoxicosis treated with antithyroid drugs. Lancet 2:898–900

    Google Scholar 

  12. Jaffiol C, Seignalet J, Baldet L, Robin M, Labinski H, Mirouze J (1976) Study of the HLA system in Basedow's disease. Ann Endocrinol (Paris) 37:111–112

    Google Scholar 

  13. Jaffiol C, Seignalet J, Baldet L, Robin M, Labinski H, Mirouze J (1976) HLA B8 and Graves' disease. Ann Endocrinol (Paris) 37:219–226

    Google Scholar 

  14. Kawa A, Nakamura S, Nakazawa M, Sakaguchi S, Kawabata T, Maeda Y, Kanehisa T (1977) HLA-Bw35 and B5 in Japanese patients with Graves' disease. Acta Endocrinol (Copenhagen) 86:754–757

    Google Scholar 

  15. Mather BA, Roberts DF, Scanlon MF, Mukhtar ED, Davies TF, Rees Smith B, Hall R (1980) HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives. Clin Endocrinol 12:155–163

    Google Scholar 

  16. Mayr WR, Ludwig H, Schernthaner G, Hofer R (1976) HLA Cw3 in thyrotoxicosis patients with and without endocrine ophthalmopathy. Tissue Antigens 7:243–246

    Google Scholar 

  17. McGregor AM, Rees-Smith B, Hall R, Petersen MN, Miller M, Dewar PJ (1980) Prediction of relapse in hyperthyroid Graves' disease. Lancet 2:1101–1103

    Google Scholar 

  18. McKenna RC, Kearns M, Sugrue D, Drury MI, McCarthy CF (1982) HLA and hyperthyroidism in Ireland. Tissue Antigens 19:97–101

    Google Scholar 

  19. Rose NR, Friedman H, Fahey JL (1986) Manual of Clinical Laboratory Immunology, 3rd edn. American Society for Microbiology, Washington, DC

    Google Scholar 

  20. Schernthaner G, Schleusener H, Kotulla P, Finke R, Wenzel B, Mayr WR (1980) Prediction of relapse or long term remission in hyperthyroid Graves' disease. Lancet 2:373–374

    Google Scholar 

  21. Schifferdecker E, Schulz F, Schöffling K (1986) Die Bestimmung von TSH-Rezeptor-Antikörpern — klinische Wertigkeit. Klin Wochenschr 64:8–14

    Google Scholar 

  22. Schleusener H, Schernthaner G, Mayr WR, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen K, Wenzel KW (1983) HLA-DR3 and HLA-DR5 associated thyrotoxicosis — two different types of toxic diffuse goiter. J Clin Endocrinol Metab 56:781–785

    Google Scholar 

  23. Sergott RC, Felberg NT, Savino PJ, Blizzard JJ, Schatz NJ, Sanford CA (1983) Association of HLA antigen Bw35 with severe Graves' ophthalmopathy. Invest Ophthalmol Vis Sci, 24:124–127

    Google Scholar 

  24. Spielmann W, Kühnl P (1982) Blutgruppenkunde. Thieme, Stuttgart

    Google Scholar 

  25. Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982 — a survey. Immunol Rev 70:193–218

    Google Scholar 

  26. Stenszky V, Kozma L, Balazs C, Rochlitz S, Bear JC, Farid NR (1985) The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 61:735–740

    Google Scholar 

  27. Tiwari L, Terasaki PI (1985) HLA and disease associations. Springer, New York Berlin Heidelberg Tokyo

    Google Scholar 

  28. Werner SC (1977) Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J. Clin Endocrinol Metab 44:203–209

    Google Scholar 

  29. Whittingham S, Morris PJ, Martin FIR (1975) HLA-A8: A genetic link with thyrotoxicosis. Tissue Antigens 6:23–27

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik, Universitätsklinik „Bergmannsheil“, Bochum

    E. Schifferdecker

  2. Abteilung für Endokrinologie, Zentrum der Inneren Medizin, Universitätsklinikum, Frankfurt a.M

    K. Schöffling, B. Manfras & B. O. Böhm

  3. Institut für Immunhämatologie, Universitätsklinikum, Frankfurt a.M

    G. Holzberger & W. Spielmann

  4. Abteilung für Transfusionsmedizin, Universitätskrankenhaus Eppendorf, Hamburg

    P. Kühnl

Authors
  1. E. Schifferdecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Kühnl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Schöffling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Manfras
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Holzberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Spielmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. O. Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schifferdecker, E., Kühnl, P., Schöffling, K. et al. Immunogenetic markers in patients with Graves' disease. Klin Wochenschr 69, 256–260 (1991). https://doi.org/10.1007/BF01666851

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01666851

Key words

Search

Navigation